No Data
No Data
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Instil Bio Price Target Raised to $52.00/Share From $11.00 by Jefferies
Instil Bio Raised to Buy From Hold by Jefferies
Jefferies Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $52
Jefferies Maintains Instil Bio(TIL.US) With Buy Rating, Cuts Target Price to $52
Express News | Instil Bio Inc - Co's Subsidiary Secures $85.6 Mln Term Loan From Midland National Life Insurance Co
EmotionOutOfEquation : Nope 10 to 90ish$ in 1 month wait before jumping